MedTrace Logo

Follow-up Study of the RAI-Treated Hyperthyroid Patients

NCT00471458 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5222

Last updated 2007-05-10

No results posted yet for this study

Summary

Previous studies of hyperthyroid patients suggest that they remain at increased risk of cardiovascular morbidity after restoring euthyroidism.

The study objective is to compare the rate and causes of hospitalization of hyperthyroid patients treated with radioactive iodine (RAI) with those of an age- and gender-matched reference population in a long-term follow-up study.

Conditions

Sponsors & Collaborators

  • Tampere University

    lead OTHER

Principal Investigators

  • Saara Metso, MD · Tampere University Hospital, Department of Internal Medicine, FIN-33521 Tampere, Finland

  • Pia Jaatinen, MD, PhD · Medical School, University of Tampere, Tampere, FINLAND

  • Jorma Salmi, MD, PhD · Tampere University Hopsital, Department of Internal Medicine, FIN-33521 TAMPERE, FINLAND

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1969-01-31
Completion
2003-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00471458 on ClinicalTrials.gov